Condition Optimization for The Analysis of Risperidone and 9-0H-Risperidone by High-Performance Liquid Chromatography
Abstract
Keywords
Full Text:
PDFReferences
Berecz, R., Dorado, P., & Caceres, M. (2003). Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography : application to the evaluation of CYP2D6 drug interactions. 783, 213–219.
Frahnert, C., Rao, M. L., & Grasmäder, K. (2003). Analysis of eighteen antidepressants, four atypical antipsychotics, and active metabolites in serum by liquid chromatography: A simple tool for therapeutic drug monitoring. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 794(1), 35–47. https://doi.org/10.1016/S1570-0232(03)00393-3
Hplc-uv, M. (2018). Determination of Risperidone and its Active Metabolite 9-Hydroxyrisperidone in Plasma by Dispersive Liquid-Liquid Microextraction – HPLC-UV. 13(1), 57–67.
Kirschbaum, K. M., Finger, S., Vogel, F., Burger, R., Gerlach, M., Riederer, P., & Hiemke, C. (2008). LC with Column-Switching and Spectrophotometric Detection for Determination of Risperidone and 9-Hydroxyrisperidone in Human Serum. (3), 321–324. https://doi.org/10.1365/s10337-007-0506-1
Lisbeth, P., Vincent, H., Kristof, M., Bernard, S., Manuel, M., & Hugo, N. (2016). Genotype and co-medication dependent CYP2D6 metabolic activity: Effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone, and zuclopenthixol. European Journal of Clinical Pharmacology, 72(2), 175–184. https://doi.org/10.1007/s00228-015-1965-1
Mandrioli, R., Mercolini, L., Lateana, D., Boncompagni, G., & Augusta, M. (2011). Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine, and saliva by MEPS-LC-UV. Journal of Chromatography B, 879(2), 167–173. https://doi.org/10.1016/j.jchromb.2010.11.033
Naumovska, Z., Brezovska, K., Tonic-ribarska, J., Nestorovska, A. K., Sterjev, Z., Filipce, A., … Suturkova, L. (2017). Optimization of Bioanalytical LC Method for Simultaneous Determination of Risperidone And Its Active Metabolite 9-OH Risperidone in Human Plasma And Urine. 7(12), 54–64.
Patients, P., Weide, K. Van Der, & Weide, J. Van Der. (2015). The Influence of the CYP3A4* 22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, 35(3), 228–236. https://doi.org/10.1097/JCP.0000000000000319
Raggi, M. A., Bugamelli, F., Sabbioni, C., Saracino, M. A., & Petio, C. (2005). HPLC-DAD determination of plasma levels of the antipsychotic risperidone and its main metabolite for toxicological purposes. Journal of Separation Science, 28(3), 245–250. https://doi.org/10.1002/jssc.200401939
Salemi, M., Spina, E., Avenoso, A., & Facciola, G. (2000). Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-phase liquid chromatography with ultraviolet detection. 746, 173–181.
Selva, M. S., & Ramanathan, M. (2016). Concurrent determination of olanzapine, risperidone, and 9-hydroxyrisperidone in human plasma by ultra-performance liquid chromatography with diode array detection method : application to pharmacokinetic study. (June 2015), 263–268. https://doi.org/10.1002/bmc.3545
Snyder, L. R., Kirkland, J. J., & Glajch, J. L. (1997). Practical HPLC Method Development 2nd ed - L. Snyder, et al., (Wiley, 1997) (pp. 1–542). pp. 1–542.
Titier, K., Deridet, E., Cardone, E., Abouelfath, A., & Moore, N. (2002). Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose. 772, 373–378.
Zhang, J. P., Lencz, T., Geisler, S., DeRosse, P., Bromet, E. J., & Malhotra, A. K. (2013). Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia. Schizophrenia Research, 146(1–3), 285–288. https://doi.org/10.1016/j.schres.2013.01.020
Zhang, J. P., & Malhotra, A. K. (2011). Pharmacogenetics and antipsychotics: Therapeutic efficacy and side effects prediction. Expert Opinion on Drug Metabolism and Toxicology, 7(1), 9–37. https://doi.org/10.1517/17425255.2011.532787
Refbacks
- There are currently no refbacks.